Category: Editor’s Pick
Geroscience in 2025: The Expert Roundup
January 13, 2026
2025 was a good year for geroscience, marked by rapid strides and critical milestones. Yet, the path wasn’t always smooth: progress in some areas lagged, research hit dead ends, and
Longevity Biotech in 2025: The Expert Roundup
January 6, 2026
How did the year 2025 turn out for longevity biotech? Was it surprising or more of the same? Exciting or disappointing? Was the progress fast-moving or excruciatingly slow? What should
Andrea Maier on Longevity Medicine for All
October 22, 2025
Dr. Andrea Maier, Oon Chiew Seng Professor in Medicine at the National University of Singapore, is a veteran geroscientist and one of the most familiar faces in the rising field
Sam Sharifi on Fixing Our DNA
October 3, 2025
Among the hallmarks of aging, DNA damage is both one of the most important and one of the hardest to crack. A couple of years ago, when I first learned
Joe Betts-Lacroix on Retro Bio and Its Recent AI Advancement
October 2, 2025
Retro Biosciences, one of the hottest startups in the longevity field, was founded about five years ago by the tech entrepreneur Joe Betts-Lacroix with a $180 million investment from his
Two People Almost Died at RAADfest. We Went to the Experts.
September 2, 2025
Two people nearly died, and several more sought treatment, after receiving peptide injections at the last RAADfest in Las Vegas. We might not know what happened until the ongoing investigations
The Tale of One Tower: SF-Based Vertical Longevity Village
July 29, 2025
In downtown San Francisco, an entire tower is becoming a hub for longevity, AI, crypto, and robotics. It just hosted its first longevity conference. How does a group conquer a
The 2025 Longevity Summit Dublin
July 15, 2025
The 2025 Longevity Summit Dublin was held in July, and we have the highlights from the event for you along with the latest research updates and news from the conference.
Rejuve.AI: Just Another App or a Longevity Research Network?
June 5, 2025
On its website, Rejuve.AI, a company co-founded by its dynamic CEO, Jasmine Smith, and a renowned AI researcher, Ben Goertzel, promises a lot of things: to “democratize longevity, globally,” to
Michael Levin on Bioelectricity in Development and Aging
May 8, 2025
Michael Levin, professor at Tufts University and director of Allen Discovery Center, has been working for years on how bioelectrical patterns affect development and aging. His research proves that this
Playing the Long Game Towards Radical Life Extension
May 1, 2025
For most of the history of human civilization, humanity expanded at an astonishing pace: faster than exponential, nearly hyperbolic. This trend was famously described in a 1960 paper by Heinz
The Underexplored Applications of Longevity Biotechnology
February 24, 2025
No other human endeavor today holds more promise than understanding and targeting aging. The molecular mechanisms that drive aging impact overall vigor, environmental stress resistance, reproductive health, and broad disease
The Battle for Long Life Has Been Accomplished: What’s Next?
January 20, 2025
How long can people live? This is not just a foundational question in science. The answer has important public policy implications and is of interest to us all. Recent scientific
Nuclear Expression of a Mitochondrial Gene in Mice
December 6, 2024
Scientists from the Longevity Research Institute (LRI), which was formed by the merger of SENS Research Foundation and Lifespan.io, have achieved expression of an essential mitochondrial gene in the nucleus
Mehmood Khan on Aging Policy and Collaboration
December 3, 2024
I first met Dr. Mehmood Khan in 2022 at the inaugural Longevity Summit Dublin, where organizers Aubrey de Grey and Martin O’Dea made a bold decision to include policy and
Geroscience in 2025: The Expert Roundup
January 13, 2026
2025 was a good year for geroscience, marked by rapid strides and critical milestones. Yet, the path wasn’t always smooth: progress in some areas lagged, research hit dead ends, and familiar bottlenecks persisted. Against this backdrop, we asked five prominent geroscientists to share their perspectives on
Longevity Biotech in 2025: The Expert Roundup
January 6, 2026
How did the year 2025 turn out for longevity biotech? Was it surprising or more of the same? Exciting or disappointing? Was the progress fast-moving or excruciatingly slow? What should we expect in 2026? We asked five leading experts to weigh in. Where did longevity biotech
Andrea Maier on Longevity Medicine for All
October 22, 2025
Dr. Andrea Maier, Oon Chiew Seng Professor in Medicine at the National University of Singapore, is a veteran geroscientist and one of the most familiar faces in the rising field of longevity medicine, which aims to translate the early successes of geroscience into clinical practice. Parallel
Sam Sharifi on Fixing Our DNA
October 3, 2025
Among the hallmarks of aging, DNA damage is both one of the most important and one of the hardest to crack. A couple of years ago, when I first learned about Matter Bioworks at a prominent longevity conference, I was amazed at the audacity of the
Joe Betts-Lacroix on Retro Bio and Its Recent AI Advancement
October 2, 2025
Retro Biosciences, one of the hottest startups in the longevity field, was founded about five years ago by the tech entrepreneur Joe Betts-Lacroix with a $180 million investment from his friend Sam Altman, the CEO of OpenAI. Despite its hefty war chest, the company initially pursued
Two People Almost Died at RAADfest. We Went to the Experts.
September 2, 2025
Two people nearly died, and several more sought treatment, after receiving peptide injections at the last RAADfest in Las Vegas. We might not know what happened until the ongoing investigations are concluded, but we asked several experts to share their thoughts on the broader context of
The Tale of One Tower: SF-Based Vertical Longevity Village
July 29, 2025
In downtown San Francisco, an entire tower is becoming a hub for longevity, AI, crypto, and robotics. It just hosted its first longevity conference. How does a group conquer a big city? The longevity community unites tens of thousands of researchers, founders, and enthusiasts, but this
The 2025 Longevity Summit Dublin
July 15, 2025
The 2025 Longevity Summit Dublin was held in July, and we have the highlights from the event for you along with the latest research updates and news from the conference. The Summit was founded by Aubrey de Grey and Martin O’Dea in 2022 and combines a
Rejuve.AI: Just Another App or a Longevity Research Network?
June 5, 2025
On its website, Rejuve.AI, a company co-founded by its dynamic CEO, Jasmine Smith, and a renowned AI researcher, Ben Goertzel, promises a lot of things: to “democratize longevity, globally,” to enable you to “take control of your data, and harness its earning potential,” and to “unite
Michael Levin on Bioelectricity in Development and Aging
May 8, 2025
Michael Levin, professor at Tufts University and director of Allen Discovery Center, has been working for years on how bioelectrical patterns affect development and aging. His research proves that this often-overlooked part of biology is immensely important and that mastering its mechanisms might one day do
Playing the Long Game Towards Radical Life Extension
May 1, 2025
For most of the history of human civilization, humanity expanded at an astonishing pace: faster than exponential, nearly hyperbolic. This trend was famously described in a 1960 paper by Heinz von Foerster and colleagues, who extrapolated global population data to predict a so-called “Doomsday”, a demographic
The Underexplored Applications of Longevity Biotechnology
February 24, 2025
No other human endeavor today holds more promise than understanding and targeting aging. The molecular mechanisms that drive aging impact overall vigor, environmental stress resistance, reproductive health, and broad disease risk, and they fundamentally change what life means by radically changing our relationship to death. Intriguingly,
The Battle for Long Life Has Been Accomplished: What’s Next?
January 20, 2025
How long can people live? This is not just a foundational question in science. The answer has important public policy implications and is of interest to us all. Recent scientific evidence has revealed the answer, so what’s next in humanity’s never-ending battle against disease and the
Nuclear Expression of a Mitochondrial Gene in Mice
December 6, 2024
Scientists from the Longevity Research Institute (LRI), which was formed by the merger of SENS Research Foundation and Lifespan.io, have achieved expression of an essential mitochondrial gene in the nucleus and proper functioning of the protein. This could pave the way for curing diseases caused by
Mehmood Khan on Aging Policy and Collaboration
December 3, 2024
I first met Dr. Mehmood Khan in 2022 at the inaugural Longevity Summit Dublin, where organizers Aubrey de Grey and Martin O’Dea made a bold decision to include policy and advocacy discussions alongside the traditional focus on longevity research. Like many others in the audience, I